Hirsutism and acne in polycystic ovary syndrome, Best Pract Res Clin Obstet Gynaecol, vol.18, pp.737-54, 2004. ,
Combined oral contraceptive pills for treatment of acne, Cochrane Database Syst Rev, vol.7, p.4425, 2012. ,
Endocrine and clinical effects of myo-inositol administration in policystic ovary syndrome A randomized study, Gynecol. Endocrinol, vol.29, pp.375-384, 2013. ,
, Association canadienne de dermatologie. Peau, cheveux et ongles: stades de l'acné
Image, stades de l'acné, 2016. ,
, Association Française de Sécurité Sanitaire des Produits de Santé. Traitement de l'acné par voie locale et générale. Recommandations, 2007.
Opinion d'expert: Algorithme de traitement de l'acné juvénile du visage ,
, Annales De Dermatologie Et De Venereologie, 2011.
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess. Society guideline, J Clin Endocrinol Metab, vol.91, pp.4237-4282, 2006. ,
Family history as a risk factor for the polycystic ovary syndrome, J Pediatr Endocrinol Metab, vol.13, issue.5, pp.1303-1309, 2000. ,
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebocontrolled trial, J Clin Endocrinol Metab, vol.86, issue.4, pp.1626-1658, 2001. ,
The evaluation and management of hirsutism, Obstet Gynecol, vol.101, pp.995-1007, 2003. ,
, monkeys exposed to prenatal androgen excess, Fertil Steril, vol.77, issue.1, pp.167-72, 2002.
Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys, J Clin Endocrinol Metab, vol.85, issue.3, pp.1206-1216, 2000. ,
Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a dutch PCOS population, Hum Reprod, vol.16, issue.3, pp.556-60, 2001. ,
Spironolactone and ACE inhibition in chronic renal failure, N Engl J Med, vol.346, pp.456-463, 2002. ,
Ovarian androgen biosynthesis : endocrine regulation, Androgen excess disorders in women, 1997. ,
, ESHRE/ASRM sponsored PCOS consensus workshop group, vol.19, pp.41-48, 2004.
,
, Steril, vol.97, pp.28-38, 2012.
, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, vol.81, pp.19-25, 2004.
Comparison of finasteride versus flutamide in the treatment of hirsutism, Eur J Endocrinol, vol.141, issue.4, pp.361-368, 1999. ,
Efficacy of combined ethinylestradiol (0.035 mg) and cyproterone acetate (2 mg) in acne and hirsutism in women with polycystic ovary syndrome, J Obstet Gynecol, vol.17, issue.6, pp.565-573, 1977. ,
Prise en charge de l'acné chez l'adolescent. Archives De Pédiatrie, vol.14, pp.1152-1158, 2007. ,
Serum bioactive and immunoreactive luteinizing hormone and folliclestimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease, J Clin Endocrinol Metab, vol.73, pp.811-818, 1991. ,
Clinical assessment of body hair growth in women, J Clin Endocrinol, vol.21, pp.1440-1447, 1961. ,
Annales De Dermatologie Et De Venereologie, vol.137, pp.15-18, 2010. ,
Syndromes of insulin resistance. From patient to gene and back again, Diabetes, vol.41, pp.1207-1226, 1992. ,
Genetic susceptibility for polycystic ovary syndrome on chromosome 19: advances in the genetic dissection of complex reproductive traits, J Clin Endocrinol Metab, vol.90, issue.12, pp.6732-6736, 2005. ,
Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome, J Clin Endocrinol Metab, vol.86, issue.3, pp.1175-80, 2001. ,
Etiology of anovulation in polycystic ovary syndrome, Steroids, vol.63, pp.306-313, 1998. ,
Polycystic ovary syndrome, N Engl J Med, vol.333, pp.853-61, 1995. ,
URL : https://hal.archives-ouvertes.fr/hal-01859437
Risk factors for sudden intrauterine unexplained death : epidemiologic characteristics of singleton cases in Oslo, Am J Obstet Gynecol, vol.184, pp.694-702, 1986. ,
Obesity and the polycystic ovary syndrome, Int J Obesity, vol.26, pp.883-96, 2002. ,
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome, Clin Endocrinol (Oxf), vol.60, pp.241-250, 2004. ,
, , 2017.
,
Differential insulin response to myo-inositol administration in obese polycystic ovary ,
Myo-Inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome ,
, Gynecol. Endocrinol, vol.24, pp.139-183, 2008.
Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebocontrolled trial, Eur. Rev. Med. Pharmacol. Sci, vol.7, pp.151-160, 2003. ,
,
double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS, Eur. Rev ,
, Med. Pharmacol. Sci, vol.11, pp.347-54, 2007.
Seasonal variations in the severity of acne vulgaris, Int J Dermatol, vol.35, pp.116-123, 1996. ,
SieveSmith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome, Hum Reprod Update, vol.12, pp.673-83, 2006. ,
Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and firsttrimester miscarriage in women with polycystic ovary syndrome, Metabolism, vol.55, issue.3, pp.345-52, 2006. ,
Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome, Metabolism, vol.48, issue.12, pp.1589-95, 1999. ,
Surgical treatment of polycystic ovary syndrome associated with infertility, Reprod Biomed Online, vol.9, issue.1, pp.35-42, 2004. ,
The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome, Sleep Med, vol.3, issue.5, pp.401-405, 2002. ,
Inositol 1,4,5trisphosphate receptor function in human oocytes: calcium responses and oocyte activationrelated phenomena induced by photolytic release of InsP3 are blocked by a specific antibody to the type I receptor ,
, Mol Hum Reprod, vol.8, pp.912-920, 2002.
Presence and dynamic redistribution of type I inositol 1,4,5trisphosphate receptors in human oocytes and embryos during in-vitro maturation, fertilization and early cleavage divisions, Mol Hum Reprod, vol.5, pp.441-51, 1999. ,
Avant-propos: Approche dermocosmétique de l'acné chez le dermatologue, vol.137, pp.76-80, 2010. ,
Ovulation induction management of PCOS, Clin Obstet Gynecol, vol.50, pp.255-67, 2007. ,
, , 2017.
,
A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test, Fertil Steril, vol.37, issue.2, pp.161-168, 1982. ,
A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo, Endocrinology, vol.128, issue.1, pp.509-526, 1991. ,
Use of cyproterone acetate in the treatment of acne, hirsutism and virilism, J Steroid Biochem, vol.6, pp.827-863, 1975. ,
A randomized bilateral vehiclecontrolled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women, J Am Acad Dermatol, vol.57, pp.54-63, 2007. ,
Polycystic ovary syndrome and endometrial carcinoma, Lancet, vol.361, issue.9371, pp.1810-1812, 2003. ,
prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome, Best Pract Res Clin Obstet Gynaecol, vol.18, pp.671-83, 2004. ,
, Contraceptifs oraux oestroprogestatifs: préferez les "pilules" de 1ère ou 2è génération. Fiche de Bon Usage du Médicament, 2012.
, Healthwise: Health information and tools: Body fat distribution, Image, 2015.
A comparative prospective study of a chronic low-dose versus a conventional ovulation stimulation regimen using r-hFSH (Gonal-F®) in anovulatory infertile women, Hum Reprod, vol.10, pp.2688-92, 1998. ,
Decreased myoinositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls, Endocrine Journal ,
Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome, J Clin Endocrinol Metab, vol.91, pp.2789-91, 2006. ,
Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis, Hum Reprod, vol.9, pp.188-91, 1994. ,
Intrafollicular paracrine function of ovarian androgen, J Steroid Biochem, vol.27, pp.351-358, 1987. ,
Polycystic ovary syndrome and mental health: A review, Obstet Gynecol Surv, vol.61, pp.723-755, 2006. ,
10 year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med, vol.359, pp.1577-89, 2008. ,
Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables ,
, Clin Endocrino.l, vol.41, pp.463-71, 1994.
Metabolism and function of myo-inositol and inositol phospholipids, Ann Rev Nutr, vol.6, pp.563-97, 1986. ,
Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome, BMJ, vol.297, issue.6655, pp.1024-1030, 1988. ,
Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome : rationale, results, reflections and refinements, Hum Reprod Update, vol.5, pp.493-99, 1999. ,
The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study, Hum Reprod, vol.28, pp.1077-83, 2013. ,
The management of infertility associated with polycystic ovary syndrome, Reprod Biol Endocrinol, vol.1, p.109, 2003. ,
Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression, Hum Reprod, vol.7, pp.184-90, 1992. ,
Growth differentiation factor-9 promotes the growth, development, and survival of human ovarian follicles in organ culture, J Clin Endocrinol Metab, vol.87, pp.316-337, 2002. ,
Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypo-glycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo ,
, Endocrinology, vol.132, pp.652-659, 1993.
Les "step protocoles, Contracept Fertil Sex, vol.26, pp.307-318, 1998. ,
Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies, Gynecol Endocrinol, vol.1, issue.3, pp.235-280, 1987. ,
Clinical spectrum of premature pubarche : links to metabolic syndrome and ovarian hyperandrogenism, Rev Endocr Metab Disord, vol.10, pp.63-76, 2009. ,
Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women, Hum Reprod, vol.20, pp.1833-1839, 2005. ,
Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect, Clin Endocrinol (Oxf), vol.55, issue.5, pp.667-72, 2001. ,
Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome ? A systematic review and meta-analysis of extracted data, J Clin Endocrinol Metab, vol.98, pp.3332-3372, 2013. ,
A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligo-amenorrheic infertility, Fertil Steril, vol.77, pp.91-98, 2002. ,
Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility, J Clin Endocrinol Metab, 1998. ,
, Aout, 2016.
Gonadotropin therapy: new trends and insights, Int J Fertil, vol.33, issue.2, pp.85-91, 1988. ,
, International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome, 2006.
, J Obstet Gynaecol Can, vol.24, issue.1, pp.68-73, 2002.
Polycystic ovaries and polycystic ovary syndrome, Gynecol Endocrinol, vol.1, pp.113-144, 1987. ,
Use of topical minoxidil therapy for androgenetic alopecia in women, Int J Dermatol, vol.32, issue.10, pp.758-62, 1993. ,
Reduced serum glycodelin and insulin-like growth factorbinding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy, J Clin Endocrinol Metab, vol.89, pp.833-842, 2004. ,
Effects of metformin on early pregnancy loss in the polycystic ovary syndrome, J Clin Endocrinol Metab, vol.87, issue.2, pp.524-533, 2002. ,
The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest, Hum Reprod. Update, vol.10, pp.107-124, 2004. ,
Ultrasound examination of polycystic ovaries: is it worth counting the follicles?, Hum Reprod, vol.18, pp.598-603, 2003. ,
Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review, Hum Reprod. Update, vol.14, pp.15-25, 2008. ,
UE Biologie de la Reproduction, Université de Rennes, vol.1, p.6, 2015. ,
Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS, Fertil Steril, vol.75, issue.1, pp.53-61, 2001. ,
Insulinsensitizing agents as primary therapy for patients with polycystic ovarian syndrome, Hum Reprod, vol.19, issue.11, pp.2474-83, 2004. ,
The psychological and emotional impact of acne and the effect of treatment with isotretinoin, Br J Dermatol, vol.140, pp.273-82, 1999. ,
Altered vascular function in young women with polycystic ovary syndrome, J Clin Endocrinol Metab, vol.87, issue.2, pp.742-748, 2002. ,
Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus ,
, N. Engl. J. Med, vol.323, pp.373-381, 1990.
Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome, Clin Endocrinol, vol.36, pp.105-116, 1992. ,
Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome, Hum Reprod, vol.16, pp.1255-60, 2001. ,
Hair reduction: 48 months of experience with 800 nm diode laser, J Cosmet Laser Ther, vol.5, pp.146-155, 2003. ,
Human chorionic gonadotropin administration vs luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate : a meta-analysis ,
, Fertil Steril, vol.87, pp.607-619, 2007.
A systematic review of commonly used medical treatments for hirsutism in women, Clin Endocrinol (Oxf), vol.68, pp.800-805, 2008. ,
Polycystic Ovary Syndrome. Revised diagnostic criteria and long-term health consequences, Hormones, vol.4, pp.133-180, 2005. ,
Modern use of clomiphene citrate induction of ovulation, Hum Reprod. Update, vol.3, pp.359-65, 1997. ,
Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol, J Clin Endocrinol Metab, vol.5, pp.1107-1118, 1980. ,
Féminin-Masculin, 2014. ,
,
The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism, Gynecol Endocrinol, vol.17, pp.57-63, 2003. ,
Santé/nature/bien-être : L'acné, des alternatives naturelles à conseiller à l'officine. Actualités Pharmaceutiques, vol.48, pp.38-47, 2009. ,
D-chiro-inositol : its functional role in insulin action and its deficit in insulin resistance ,
, J. Exp. Diabetes Res, vol.3, pp.47-60, 2002.
Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age, J Clin Endocrinol Metab, vol.89, pp.318-341, 2004. ,
, Prise en charge de l'acné
, Traitement de l'acné par voie locale et générale
, , vol.23, pp.213-234, 2016.
Les problèmes capillaires. Rev. Le moniteur des pharmacies, cahier de formation, 2011. ,
, Quelques réflexions sur l'acné en, 2014.
, Image
,
, Gynécologie Obstétrique & Fertilité, vol.32, pp.193-201, 2004.
,
, Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome, N Engl J Med, vol.356, pp.551-66, 2007.
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome : a prospective, controlled study in 254 aff ected women, J Clin Endocrinol Metab, vol.84, pp.165-174, 1999. ,
Female pattern alopecia: current perspectives, Int J Womens Health, vol.5, pp.541-56, 2013. ,
Recurrent miscarriage: principles of management, Hum Reprod, vol.13, issue.2, pp.478-82, 1998. ,
PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma, Am J Cancer Res, 2014. ,
, Jan, vol.15, issue.1, pp.73-82
Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes, Endocrinology, vol.112, pp.1460-1468, 1983. ,
Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy, Reprod Biomed Online, vol.9, issue.4, pp.382-90, 2004. ,
Metformin in polycystic ovary syndrome: systematic review and meta-analysis, BMJ, vol.327, issue.7421, pp.951-954, 2003. ,
Maturation, fertilization, and the structure and function of the endoplasmic reticulum in cryopreserved mouse oocytes, Biol Reprod, 2009. ,
CA-100: Le traitement du diabète gestationnel par myo-inositol permet d'éviter l'insulinothérapie dans ¾ des cas. Résultats d'une étude pilote, Diabetes & Metabolism, vol.42, p.62, 2016. ,
Androgènes chez la femme : biosynthèse et mode d'action ,
, Reproduction Humaine et Hormones, vol.5, pp.1-6, 1995.
Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome, Hum Reprod, vol.22, pp.3197-203, 2007. ,
Le syndrome des ovaires micropolykystiques (OMPK): le point de vue de l'endocrinologue. Document présenté lors: Conférence de l'ALFORMEC, Clinique Saint Luc. Figure, p.6, 2011. ,
Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, vol.93, issue.4, pp.1105-1125, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-01847374
, Martindale: The Complete Drug Reference. Clomifene citrate: Adverse effects
EMCCosmétologie et Dermatologie esthétique, 2002. ,
Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity, 2000. ,
Lack of effect of spironolactone on hair shaft diameter in hirsute females, Postgrad Med J, vol.65, pp.459-62, 1989. ,
Minoxidil: mechanisms of action on hair growth, Br J Dermatol, 2004. ,
, Editions Med'Com, 2008.
Treatment of hirsutism with myo-inositol: a prospective clinical study, Reprod. Biomed, vol.17, pp.579-82, 2008. ,
Troglitazone: a possible modulator of ovarian steroidogenesis, J Soc Gynecol Investig, vol.9, issue.3, pp.163-170, 2002. ,
Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6 month trial, followed by open, longterm clinical evaluation, J Clin Endocrinol Metab, vol.85, pp.139-185, 2000. ,
Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebocontrolled trial, J Clin Endocrinol Metab, vol.85, pp.89-94, 2000. ,
Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial, BMJ, vol.332, p.1485, 2006. ,
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome : a systematic review and meta-analysis, Hum Reprod. Update, vol.16, pp.347-63, 2010. ,
The role of inositol supplementation in patients with polycystic ovary syndrome ,
, Fertil. Steril, vol.95, pp.2642-2646, 2011.
Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day) ,
, Gynecol Endocrinol, vol.14, issue.1, pp.38-41, 2000.
Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility : a meta-analysis, Hum Reprod. Update, vol.9, pp.429-478, 2003. ,
Effect of androgens on the development of mouse follicles growing in vitro, J Reprod Fertil, vol.113, pp.27-33, 1998. ,
Metabolic regulation of androgen production by human thecal cells in vitro, Hum Reprod, vol.10, pp.75-81, 1995. ,
,
The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome, J Clin Endocrinol Metab, vol.86, issue.12, pp.5925-5958, 2001. ,
Effects of metformin on spontaneous and clomipheneinduced ovulation in the polycystic ovary syndrome, N Engl J Med, vol.338, pp.1876-80, 1998. ,
Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome, N Engl J Med, vol.335, pp.617-640, 1996. ,
A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome, J Clin Endocrinol Metab, vol.72, pp.83-92, 1991. ,
Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis, Fertil Steril, vol.58, pp.655-66, 1992. ,
Polycystic ovary syndrome, Lancet, vol.370, pp.685-97, 2007. ,
the treatment of hirsutism, J Clin Endocrinol Metab, vol.72, pp.1008-1021, 1991. ,
Figure 1 : Représentation schématique de différents protocoles de stimulation de l'ovulation par la FSH recombinante, vol.235, p.8, 2004. ,
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men, J. Am ,
, , vol.47, pp.377-85, 2002.
Cardiopulmonary impairment in young women with polycystic ovary syndrome, J Clin Endocrinol Metab, vol.91, issue.8, pp.2967-71, 2006. ,
Early impairment of endothelial structure and function in young normalweight women with polycystic ovary syndrome, J Clin Endocrinol Metab, vol.89, issue.9, pp.4588-93, 2004. ,
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study, J Clin Endocrinol Metab, vol.89, issue.8, pp.3696-701, 2004. ,
Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome?, Histopathology, vol.19, issue.5, pp.445-52, 1991. ,
Evidence-based and potential benefits of metformin in polycystic ovary syndrome, Endocr Rev, vol.30, pp.1-50, 2009. ,
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome : a prospective controlled study, Hum Reprod, vol.21, pp.2823-2832, 2006. ,
Androcur 50 mg comprimé sécable (cyprotérone) simplification du schéma thérapeutique ,
Myo-Inositol in patients with polycystic ovary syndrome: a novel method for ,
Antiandrogenic activity of norgestimate in human androgen-dependent stable-transfected cell line ,
, Gynecol Endocrinol, vol.23, pp.193-200, 2007.
Normal regulation of adrenal androgen production, Androgen excess disorders in women, pp.23-35, 1997. ,
Obesity and reproductive disorders in women, Hum Reprod. Update, vol.9, pp.359-72, 2003. ,
Histologie des appareils génitaux. Module intégré Génétique Reproduction Développement de PCEM 2, vol.1, p.32, 2008. ,
Le syndrome des ovaires polykystiques (OPK) et l'infertilité ,
, Aspect échographique typique d'un ovaire polykystique, Image
Psychiatric morbidity in dermatological outpatients: an issue to be recognized, Br J Dermatol, vol.143, pp.983-91, 2000. ,
Mortality of women with polycystic ovary syndrome at longterm follow-up, J Clin Epidemiol, vol.51, pp.518-86, 1998. ,
Serum antimullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome ,
, J Clin Endocrinol Metab, vol.91, pp.941-946, 2006.
Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome : relationship to the ovarian follicle excess and to the follicular arrest, J Clin Endocrinol Metab, vol.88, pp.5957-62, 2003. ,
The association between polycystic ovaries and endometrial cancer, Hum Reprod, vol.21, issue.4, pp.924-933, 2006. ,
Compléments alimentaires: Rôle de la complémentation orale pour lutter contre la chute de cheveux. Actualités Pharmaceutiques, pp.39-40, 2011. ,
Regulation of serum sex hormone binding globulin levels in PCOS, Androgen excess disorders in women, pp.497-505, 1997. ,
The insulin-related ovarian regulatory system in hand disease, Endocr Rev, vol.20, pp.535-82, 1999. ,
Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment, J. Am. Acad. Dermatol, vol.41, pp.717-738, 1999. ,
, , 2017.
Pathophysiology of sex hormone binding globulin (SHBG) : relation to insulin, J Steroid Biochem Mol Biol, vol.40, pp.841-850, 1991. ,
Recommendations for investigation of hyperandrogenism, Ann Endocrinol, vol.71, pp.2-7, 2010. ,
Impaired glucose tolerance in pregnant women with polycystic ovary syndrome, Obstet Gynecol, vol.94, pp.194-201, 1999. ,
Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women ,
, , vol.26, pp.275-80, 2010.
Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study, Hum Reprod, vol.21, issue.6, pp.1400-1407, 2006. ,
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome, J Clin Invest, vol.57, pp.1320-1329, 1976. ,
Hypersecretion of luteinising hormone, infertility, and miscarriage, Lancet, vol.336, pp.1141-1145, 1990. ,
Electrolysis for the treatment of hypertrichosis and hirsutism, Skin Therapy Lett, vol.4, issue.6, pp.3-4, 1999. ,
Peripheral actions of androgens, Androgen excess disorders in women, pp.63-71, 1997. ,
Syndrome des ovaires polymicrokystiques, Encycl Méd Chir, vol.10027, p.10, 2007. ,
Selective effects of pioglitazone on insulin and androgen abnormalities in normo-and hyperinsulinaemic obese patients with polycystic ovary syndrome, Hum Reprod, vol.18, issue.6, pp.1210-1218, 2003. ,
What every physician should know about polycystic ovary syndrome, Dermatol Ther, vol.21, pp.354-61, 2008. ,
DOI : 10.1111/j.1529-8019.2008.00217.x
Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov, 2012. ,
DOI : 10.2174/187221312800166859
PA052: L'hypertension artérielle au cours du syndrome des ovaires polykystiques (SOPK) ,
DOI : 10.1016/j.ando.2015.07.213
, , vol.76, p.367, 2015.
Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome, Acta Obstet Gynecol Scand, vol.92, pp.1369-74, 2013. ,
Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome, Proc Natl Acad Sci. USA, vol.103, pp.7030-7035, 2006. ,
Drug discovery for alopecia: gone today, hair tomorrow, Expert Opin Drug Discov, vol.10, issue.3, pp.269-92, 2015. ,
Figure 2: La stéroïdogénèse et le modèle "2 cellules, 2 gonadotrophines, 2007. ,
Androgenetic alopecia. New approved and unapproved treatments, Dermatol Clin, vol.18, pp.47-61, 2000. ,
Multiple pregnancies following induction of ovulation, Fertil Steril, vol.35, pp.105-128, 1981. ,
Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis, Mol. Nutr. Food Res, p.53, 2009. ,
Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome, Fertil Steril, vol.64, issue.6, pp.1081-1088, 1995. ,
Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension, J Matern Fetal Neonatal Med, vol.21, issue.8, pp.581-586, 2008. ,
Removal of unwanted facial hair, Am Fam Physician, vol.66, issue.10, pp.1907-1918, 2002. ,
Diffuse hair loss in an adult female: Approach to diagnosis and management, Indian J Dermatol Venereol Leprol, vol.75, pp.20-28, 2009. ,
Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness, Br J Dermatol, vol.165, issue.3, pp.12-20, 2011. ,
Pharmacological profile of progestins, Maturitas, pp.277-83, 2004. ,
Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial, Dermatol Surg, vol.32, pp.1237-1280, 2006. ,
, Traitement de l'acné par voie locale et générale, 2015.
Menstrual cycle irregularity and risk for future cardiovascular disease, J Clin Endocrinol Metab, vol.87, issue.5, pp.2013-2020, 2002. ,
Spironolactone as a single agent for long-term therapy of hirsute patients, Clin Endocrinol (Oxf), vol.52, pp.587-94, 2000. ,
DOI : 10.1046/j.1365-2265.2000.00982.x
Transient release of calcium from inositol 1,4,5-trisphosphate-specific stores regulates mouse preimplantation development ,
, , vol.122, pp.2485-96, 1996.
A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome, Fertil Steril, vol.81, pp.630-637, 2004. ,
Pharmacokinetics and potency of progestins used for hormone replacement therapy contraception, Rev Endocr Metab Disord, vol.3, pp.211-235, 2002. ,
Amenorrhea associated with bilateral polycystic ovaries, Am J Obstet Gynecol, vol.29, pp.181-91, 1935. ,
Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity, J Clin Endocrinol Metab, vol.91, pp.4112-4119, 2006. ,
, Stop calvitie: Comprendre et traiter l'alopécie androgénétique, 2015.
Both myoinositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls, Biochem Biophys Res Commun, vol.293, pp.1092-1100, 2002. ,
Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials, J Clin Endocrinol Metab, vol.93, pp.1153-60, 2008. ,
Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome, Hum Reprod, vol.11, pp.1387-92, 1996. ,
Coronary heart disease risk factors in women with polycystic ovary syndrome, Arterioscler Thromb Vasc Biol, vol.15, pp.821-827, 1995. ,
Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, doubleblind multicentre study, Hum Reprod, vol.21, issue.1, pp.80-89, 2006. ,
Insulinsensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility, Cochrane Database Syst Rev, vol.5, p.3053, 2012. ,
Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome, J Clin Endocrinol Metab, vol.91, issue.1, pp.36-42, 2006. ,
Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome ,
, J Clin Endocrinol Metab, vol.87, pp.1337-1381, 2002.
Le syndrome des ovaires polykystiques (SOPK), J Gynecol Obstet Biol Reprod (Paris), vol.36, pp.423-469, 2007. ,
DOI : 10.1016/j.jgyn.2007.04.002
Le syndrome des ovaires polykystiques (SOPK), J Gynecol Obstet Biol Reprod (Paris), vol.36, p.426, 2007. ,
DOI : 10.1016/j.jgyn.2007.04.002
Le syndrome des ovaires polykystiques (SOPK), J Gynecol Obstet Biol Reprod (Paris), vol.36, p.427, 2007. ,
DOI : 10.1016/j.jgyn.2007.04.002
,
, diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis
, Fertil Steril, vol.92, pp.667-77, 2009.
Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome, Acta Obstet Gynecol Scand, vol.84, issue.12, pp.1192-1198, 2005. ,
Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus, J Clin Endocrinol Metab, vol.86, pp.446-455, 2001. ,
Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review, Acta Obstet Gynecol Scand, vol.84, pp.611-617, 2005. ,
Effects of myo-inositol in women with PCOS: A systematic review of randomized controlled trials ,
, Gynecol Endocrinol, vol.28, pp.509-524, 2012.
Hyperinsulinemia alters myoinositol to d-chiroinositol ratio in the follicular fluid of patients with PCOS, Reprod Sci, vol.21, pp.854-862, 2014. ,
Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial, Eur. Rev. Med. Pharmacol. Sci, vol.15, pp.452-459, 2011. ,
Thirtyseven candidate genes for polycystic ovary syndrome : strongest evidence for linkage is with follistatin, Proc Natl Acad Sci USA, vol.96, pp.8573-8581, 1999. ,
Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2, J Clin Endocrinol Metab, vol.90, pp.6623-6632, 2005. ,
Quality of life and maladjustment associated with hair loss in women with alopecia androgenetica, Social Science and Medicine, vol.38, issue.1, pp.159-63, 1998. ,